Paradiem’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-136,294
Closed -$2.55M 93
2024
Q1
$2.55M Buy
136,294
+72,244
+113% +$1.44M 0.63% 62
2023
Q4
$1.45M Sell
64,050
-67,939
-51% -$1.47M 0.4% 69
2023
Q3
$3.27M Buy
131,989
+6,341
+5% +$160K 0.98% 54
2023
Q2
$3.53M Buy
125,648
+30,654
+32% +$761K 1.01% 51
2023
Q1
$2.12M Buy
94,994
+32,717
+53% +$857K 0.66% 73
2022
Q4
$1.65M Buy
+62,277
New +$2.03M 0.61% 72

Other funds holding CCRN

Paradiem's CCRN Position: Q2 2024 in Review

Paradiem sold out of Cross Country Healthcare (CCRN) in Q2 2024, closing a stake of 136,294 shares — an estimated $2.55M sold.

Paradiem first reported a position in CCRN in Q4 2022 and held it in 6 quarters. The position peaked at $3.53M in Q2 2023. 162 funds tracked by Wall St. Rank hold CCRN as of Q2 2024.

  • Paradiem reported no remaining Cross Country Healthcare position as of Q2 2024 after selling out during the quarter.
  • Paradiem sold 136,294 Cross Country Healthcare shares in Q2 2024, an estimated $2.55M.
  • Paradiem first reported a position in Cross Country Healthcare in Q4 2022 and held it in 6 quarters.
  • Paradiem's Cross Country Healthcare position peaked at $3.53M in Q2 2023.
  • 162 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2024.

Based on Paradiem's 13F filing for Q2 2024, filed 22 Jul 2024.